Rationale and design of the STOP-IMH randomised trial: Safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and... by E.C.I. Woelders, B. Yosofi, D.A.M. Peeters, L.S.F. Konijnenberg, C. von Birgelen, J.B. van Rees, S.C.H. van den Oord, A.A.C.M. Heestermans, B.E.P.M. Claessen, N. van Royen, R.J.M. van Geuns, R. Nijveldt, P. Damman

Get full text